Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James R. Murphy currently holds 75,590 shares of BENTLEY PHARMACEUTICALS INC (BNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James R. Murphy has been a net neutral trader of BNT stock. They have purchased $0 and sold $0 worth of shares.
James R. Murphy's most recent insider trade was on Apr 5, 2011, when they sold 7,000 shares at $0.00 per share.
James R. Murphy serves as Executive at BENTLEY PHARMACEUTICALS INC (BNT). They have executed 21 insider transactions totaling $0 over their tenure at the company.
James R. Murphy holds the position of Executive at BENTLEY PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
James R. Murphy has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by James R. Murphy was on Jul 22, 2008, when they sold $6.4M worth of BNT shares. This transaction involved 428,903 shares at $14.82 per share.
James R. Murphy currently owns 75,590 shares of BENTLEY PHARMACEUTICALS INC (BNT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James R. Murphy's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James R. Murphy has 21 Form 4 filings on record as an insider at BENTLEY PHARMACEUTICALS INC.
Set alerts for James R. Murphy and 40,000+ other insiders.